SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-18-064340
Filing Date
2018-10-29
Accepted
2018-10-29 13:03:38
Documents
1
Group Members
ZENECA INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D a18-37255_1sc13d.htm SC 13D 172423
  Complete submission text file 0001104659-18-064340.txt   174348
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filed by) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Subject) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90691 | Film No.: 181143502
SIC: 2834 Pharmaceutical Preparations